PapersFlow Research Brief
Fluorine in Organic Chemistry
Research Guide
What is Fluorine in Organic Chemistry?
Fluorine in organic chemistry is the incorporation and study of fluorine atoms or fluorinated groups into organic molecules to modify their physical, chemical, and biological properties due to the unique strength and polarity of the carbon-fluorine bond.
The field encompasses over 105,000 published works on fluorine-containing organic compounds. Fluorine substitution forms the strongest bonds in organic chemistry, making it attractive for pharmaceuticals and materials. Organofluorine compounds affect adsorption, distribution, metabolism, and excretion properties of lead compounds.
Research Sub-Topics
Fluorine in Medicinal Chemistry
This sub-topic explores fluorination strategies enhancing drug pharmacokinetics, binding affinity, and metabolic stability. Researchers study SAR of fluorinated pharmaceuticals across therapeutic areas.
C-F Bond Activation
This sub-topic develops catalytic methods for selective C-F bond cleavage and functionalization in polyfluorinated compounds. Researchers innovate transition-metal and organocatalytic approaches.
Fluorine-Containing Pharmaceuticals
This sub-topic catalogs and analyzes clinically approved fluorinated drugs and pipeline candidates. Researchers track structural trends, therapeutic areas, and fluorine's role in efficacy.
Organofluorine Bioisosteres
This sub-topic investigates fluorinated groups mimicking hydrogen bond donors or heterocycles in drug scaffolds. Researchers quantify bioisosteric equivalency through computational and experimental studies.
Fluorination Methods in Synthesis
This sub-topic advances late-stage fluorination, electrophilic/ nucleophilic reagents, and radical processes. Researchers develop regioselective C-H fluorination for complex molecules.
Why It Matters
Fluorine incorporation enhances metabolic stability and pharmacokinetic properties of drug molecules, with approximately 30% of pharmaceuticals containing fluorine as noted in recent studies on silver(II) fluoride reactivity. Purser et al. (2007) in 'Fluorine in medicinal chemistry' highlight fluorinated drugs like those targeting specific modes of action, contributing to 7247 citations reflecting their therapeutic impact. Wang et al. (2013) in 'Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)' document numerous market-approved drugs from 2001-2011, demonstrating fluorine's role in advancing treatments across industries. Recent breakthroughs, such as NUS researchers' catalytic conversion of epoxides to fluorinated oxetanes (2025), enable synthesis of previously inaccessible drug candidates.
Reading Guide
Where to Start
'Understanding organofluorine chemistry. An introduction to the C–F bond' by O’Hagan (2007) provides foundational knowledge on C-F bond properties essential before advancing to applications.
Key Papers Explained
O’Hagan (2007) introduces C-F bond basics, which Purser et al. (2007) in 'Fluorine in medicinal chemistry' and Müller et al. (2007) in 'Fluorine in Pharmaceuticals: Looking Beyond Intuition' apply to drug design, showing fluorine's property modifications. Wang et al. (2013) in 'Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)' builds chronologically on these by cataloging real-world approvals, while Liang et al. (2013) in 'Introduction of Fluorine and Fluorine‐Containing Functional Groups' details synthetic methods enabling such compounds.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints focus on C-F bond activation, including photoexcited nickel-catalyzed arylation of polyfluoroarenes and defluoro carbon-carbon coupling from UNC chemists. NUS breakthrough converts epoxides to fluorinated oxetanes for drug synthesis. Photocatalytic strategies target PFAS C-F bonds.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Fluorine in medicinal chemistry | 2007 | Chemical Society Reviews | 7.2K | ✕ |
| 2 | Fluorine in Pharmaceuticals: Looking Beyond Intuition | 2007 | Science | 6.4K | ✕ |
| 3 | Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs... | 2013 | Chemical Reviews | 4.6K | ✕ |
| 4 | Understanding organofluorine chemistry. An introduction to the... | 2007 | Chemical Society Reviews | 3.8K | ✕ |
| 5 | The Many Roles for Fluorine in Medicinal Chemistry | 2008 | Journal of Medicinal C... | 3.5K | ✓ |
| 6 | Applications of Fluorine in Medicinal Chemistry | 2015 | Journal of Medicinal C... | 3.4K | ✓ |
| 7 | Next Generation of Fluorine-Containing Pharmaceuticals, Compou... | 2016 | Chemical Reviews | 2.6K | ✕ |
| 8 | Dual Catalysis Strategies in Photochemical Synthesis | 2016 | Chemical Reviews | 2.6K | ✓ |
| 9 | Introduction of Fluorine and Fluorine‐Containing Functional Gr... | 2013 | Angewandte Chemie Inte... | 2.5K | ✓ |
| 10 | Fluorine and Fluorinated Motifs in the Design and Application ... | 2018 | Journal of Medicinal C... | 2.4K | ✓ |
In the News
Breakthrough method opens door to fluorinated oxetane ...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts epoxides into fluorinated oxetanes, a coveted but difficult-to-make class of ...
Selective arylation of atypical C–F bonds in polyfluoroarenes with aryl chlorides
Selective activation of specific C–F bonds in polyfluoroarenes represents a challenge in transition metal catalysis. Here we report a photoexcited nickel-catalysed cross-electrophile coupling betwe...
Cross-electrophile coupling of polyfluoroarenes and aryl chlorides
The selective activation of specific C–F bonds in polyfluoroarenes remains challenging. Now, the selective arylation of atypical C–F bonds in polyfluoroarenes is achieved through a photoexcited nic...
Photocatalytic C–F bond activation in small molecules and polyfluoroalkyl substances
However, the activation of carbon–fluorine (C–F) bonds—the most commercially abundant organohalide and found in polyfluoroalkyl substances (PFAS), or ‘forever chemicals’—is much rarer. Current appr...
Putting the F in pharma | Feature
Perhaps the biggest breakthrough in fluorination came in 2023, with a method that goes back to the source of all fluorine-containing reagents – the mineral fluorspar, calcium fluoride. At the Unive...
Code & Tools
## Repository files navigation # Fluorify Perform Fluorine scanning analysis on trajectories. # Installation - via conda conda config --add ch...
1. Create an end-to-end process to run quantum chemistry experiments using canidate molecules that are representative of PFAS, taking into account ...
The CDK is an open-source Java library for cheminformatics and bioinformatics. Key Features: * Molecule and reaction valence bond representation. *...
| O | Oxygen | 8 | 0.015999400 | 3.44 | | F | Fluorine | 9 | 0.018998403 | 3.98 | | Ne | Neon | 10 | 0.020179700 | 0.00 | | Na | Sodium | 11 | 0.02...
**CAT**is a collection of tools designed for the construction of various chemical compounds. Further information is provided in the documentation ....
Recent Preprints
Metabolic Stability of Fluorinated Small Molecules: A Physical ...
The incorporation of fluorine and fluorinated motifs into medicinally relevant scaffolds can improve the metabolic and pharmacokinetic properties (DMPK) of drug molecules. Typically, this phenomeno...
Harnessing the Radical Reactivity of Silver(II) Fluoride for ...
The high electronegativity and small size of a fluorine atom imparts unique properties to molecules. It is well established that introduction of fluorine into drug molecules can enhance efficacy an...
Recent developments in the use of fluorinated esters as ...
studied. The incorporation of fluorine atoms is one approach that has been gaining much attention in this area. Whilst fluorine is the most electronegative element, its large Csp3–F bond energy of ...
UNC Chemists Find Gentler Way to Reshape Fluorine Bonds ...
In the first study, published in*Organic Letters*, Rosario-Collazo, Professor Meek and Dr. Hawa Keita, a Ph.D. graduate in chemistry, developed a method utilizing defluoro carbon–carbon coupling, w...
Selective arylation of atypical C–F bonds in polyfluoroarenes with aryl chlorides
## References 01. Muller, K., Faeh, C. & Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition. _Science_ **317**, 1881–1886 (2007). PubMed Google Scholar
Latest Developments
Recent developments in fluorine in organic chemistry research include advancements in selective C–F bond activation through photoexcited nickel-catalyzed cross-electrophile coupling with aryl chlorides (published October 2025) (Nature Chemistry), and progress in photocatalytic activation of C–F bonds in small molecules and polyfluoroalkyl substances (published November 2024) (Nature). Additionally, research continues into synthetic strategies for organofluorine compounds, as well as the development of fluorine-containing materials and applications in energy storage and materials science (Nature Reviews Methods Primers, Nature).
Sources
Frequently Asked Questions
What makes the C-F bond unique in organic chemistry?
The C-F bond is the strongest single bond to carbon in organic chemistry due to fluorine's high electronegativity of 3.98 and bond energy up to 456 kJ/mol in CF4. O’Hagan (2007) in 'Understanding organofluorine chemistry. An introduction to the C–F bond' explains its high polarity and resistance to metabolism. This property enhances stability in pharmaceuticals.
How does fluorine affect drug properties?
Fluorine substituents influence conformation, lipophilicity, and metabolic stability of drug molecules. Müller et al. (2007) in 'Fluorine in Pharmaceuticals: Looking Beyond Intuition' state that organofluorine impacts adsorption, distribution, metabolism, and excretion. Hagmann (2008) in 'The Many Roles for Fluorine in Medicinal Chemistry' details roles in blocking metabolism and mimicking functional groups.
What methods introduce fluorine into organic molecules?
Organo- and transition-metal catalysis enable C-F bond formation, addressing challenges from fluorine's high bond strength. Liang et al. (2013) in 'Introduction of Fluorine and Fluorine‐Containing Functional Groups' review advances in selective fluorination. Recent preprints describe photoexcited nickel-catalyzed C-F activation in polyfluoroarenes.
Which fluorine-containing drugs were approved between 2001-2011?
Wang et al. (2013) in 'Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)' catalog drugs entering the market in that period. These compounds leverage fluorine for improved efficacy and pharmacokinetics. The review cites specific examples across therapeutic areas.
What is the current state of fluorine in clinical trials?
Zhou et al. (2016) in 'Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas' analyze phase II-III candidates. Fluorine motifs continue in new structural trends for major companies. Gillis et al. (2015) in 'Applications of Fluorine in Medicinal Chemistry' note expanding sophistication in deployment.
Open Research Questions
- ? How can selective activation of specific C-F bonds in polyfluoroarenes be achieved without affecting others?
- ? What mechanisms underlie metabolic stability improvements from fluorinated motifs beyond C-H vs C-F bond strength differences?
- ? Can gentler methods for breaking C-F bonds enable controlled defluorinative carbon-carbon coupling in complex molecules?
- ? How do photocatalysts facilitate C-F bond activation in polyfluoroalkyl substances like PFAS?
- ? What new structural trends in fluorine-containing pharmaceuticals emerge from phase II-III trials?
Recent Trends
Selective C-F bond activation in polyfluoroarenes via photoexcited nickel catalysis with aryl chlorides emerged in 2025 preprints.
Metabolic stability studies emphasize mechanisms beyond bond strengths in fluorinated small molecules.
NUS researchers reported epoxide-to-fluorinated oxetane conversion in February 2025, accessing new drug scaffolds.
UNC chemists developed defluorinative C-C coupling in Organic Letters , enabling controlled C-F reshaping.
2025Research Fluorine in Organic Chemistry with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Fluorine in Organic Chemistry with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.